Literature DB >> 1937676

Angiotensin converting enzyme inhibitors. An overview.

M A Ondetti1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1937676     DOI： 10.1161/01.hyp.18.5_suppl.iii134

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

Review 1.  Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

Authors:  Lijun Shi; Caiping Mao; Zhice Xu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-02-17       Impact factor: 7.851

2.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

Review 3.  A story of two ACEs.

Authors:  Ursula Danilczyk; Urs Eriksson; Michael A Crackower; Josef M Penninger
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

4.  Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.

Authors:  L Criscione; M de Gasparo; P Bühlmayer; S Whitebread; H P Ramjoué; J Wood
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function.

Authors:  Hao Wang; Xuming Sun; Sarfaraz Ahmad; Jing Su; Carlos Maria Ferrario; Leanne Groban
Journal:  Mol Cell Biochem       Date:  2019-02-02       Impact factor: 3.396

6.  The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.

Authors:  Zatul-'Iffah Abu Hasan; Helen Williams; Nur M Ismail; Hidayatulfathi Othman; Gyles E Cozier; K Ravi Acharya; R Elwyn Isaac
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.